PT-141 (Bremelanotide) is a synthetic peptide analog derived from the melanocortin peptide family and has been studied for its interaction with melanocortin receptors, particularly MC3 and MC4 receptor pathways. Unlike peptides that primarily influence peripheral metabolic processes, PT-141 has been investigated for its effects on central nervous system signaling, melanocortin receptor activity, and neuroendocrine pathways. Preclinical and clinical research has explored its role in understanding melanocortin system regulation, receptor pharmacology, and behavioral responses associated with neural signaling. Research involving PT-141 focuses on peptide-receptor interactions, central signaling mechanisms, and physiological responses within controlled experimental settings.
Peptides are available for research purposes only.
Please review and adhere to our Terms and Conditions before ordering.
Reviews
There are no reviews yet.